drugset / Trial / NCT00003630

Arsenic Trioxide in Treating Patients With Advanced Solid Tumors

NCT00003630

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of arsenic trioxide in treating patients who have advanced solid tumors.

Timeline

Start
1998-08
Primary completion
2000-08
Completion
2000-08

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule Intravenous